New Strategies to Improve Oral Drug Delivery for Disease Treatment
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (31 January 2025) | Viewed by 1863
Special Issue Editors
2. Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China
Interests: biomaterials; drug delivery; cancer immunotherapy; nanomedicine; cancer nanotechnology; molecular pharmaceutics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Oral administration provides a non-invasive and convenient approach for drug delivery. However, a wide range of drugs (e.g., peptides, proteins, anticancer drugs and vaccines) must be parenterally injected due to their poor oral bioavailability within the harsh gastrointestinal environment (such as low pH and various digestive enzymes), due to the presence of mucosal barries, epithelial barriers and spatiotemporal variance in physiological parameters. By overcoming the biological, chemical and physiological barriers of the gastrointestinal tract, strategies such as the use of nanoparticles, chemical enhancers, prodrugs and oral devices could represent leading and innovative approaches for treating many diseases via the oral route, especially gastrointestinal diseases and chronic diseases.
This Special Issue aims to report on research and breakthroughs in the field of oral drug delivery. We invite research articles and review articles that focus on interesting approaches to oral drug delivery and improved treatment strategies for various diseases.
Prof. Dr. Lin Mei
Prof. Dr. Yining Xu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- oral delivery
- gastrointestinal diseases
- chronic diseases
- gastrointestinal tract
- biologic agents
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
